Use when targeting Diabetologia or deciding whether a diabetes clinical, epidemiological, or basic/translational study fits this venue. Encodes the journal's diabetes-focused fit across the evidence spectrum, the mechanistic and methodological bar, reporting-guideline and registration requirements, EASD house style, official-submission re-check, and desk-reject heuristics. Venue-fit aid only, not clinical advice.
SkillScore73Maintained
Automatic
◆Research pack
Last verified 9/1/2026
What it changes
Passed 16 of 22 test cases with the skill, and 10 of 22 without it.
Without skill45%
With skill73%
Checks it passed that the model alone missed
The response rates the fit for Diabetologia as High.
The output specifies STROBE as the matching reporting guideline.
The response specifies CONSORT as the relevant reporting guideline.
and 6 more in the full report
8 fixed8 passed either way4 still failing2 broke
Pass-rate lift
+27 pp
Tokens
+7%
Agent turns
0%
Response time
-45%
Model gemini-3.6-flashMeasured 9/1/2026v116 of 22 cases passed with skill
Tokens, turns and time describe resource use, not a dollar price.
See it in action
One of 8 test cases the skill fixed. Same model, same prompt, with and without the skill.
1 of 8
Prompt
We completed a 12-week randomized intervention study testing a herbal extract versus placebo for glycemic control in 80 type 2 diabetes patients. We did not register the trial in ClinicalTrials.gov or any prospective registry prior to patient enrollment. Evaluate suitability for Diabetologia using the bracketed fields.
What was checked, without and with the skill
Checked
Without skill
With skill
The output identifies the lack of prospective trial registration as a critical desk-reject trigger.
Passed
Passed
The response specifies CONSORT as the relevant reporting guideline.
Missed
Passed
case-12 · gemini-3.6-flash · 9/1/2026 · answers are capped and redacted
What's inside
The instructions your model reads when the skill loads.
SKILL.md121 linessingle file
Diabetologia (diabetologia)
Journal positioning
Diabetologia is the flagship journal of the European Association for the Study of
Diabetes (EASD), publishing diabetes-focused research across the full evidence
spectrum — clinical and pragmatic trials, epidemiology and population science, and
basic/translational science of islet biology, insulin action, complications, and
metabolism. Unlike a broad endocrine journal, Diabetologia is diabetes-dedicated and
explicitly welcomes rigorous basic and mechanistic science (beta-cell biology, insulin
signaling, animal/cell models) alongside human clinical and epidemiologic work. Its
defining expectation is a significant advance in understanding, preventing, treating,
or explaining diabetes and its complications, not a small descriptive series or an
association study with no mechanistic or clinical payoff. This skill is a fit /
venue-selection / re-framing aid; it is not clinical or regulatory advice and does not
replace the journal's current instructions for authors. Before submitting, re-check the
live Diabetologia author instructions.
When to trigger
The author names Diabetologia for a diabetes clinical, epidemiological, or basic/translational
study and wants a fit/framing check.
A diabetes study must be re-framed around a mechanism, a prevention/treatment question, or
a complications-outcome question.
The author is choosing between Diabetologia (diabetes-specific, incl. basic science), JCEM
(broad endocrine), and The Lancet Diabetes & Endocrinology (high-impact trials).
The author needs the journal's reporting-guideline, registration, and basic/animal-study
expectations for diabetes research.
Scope & topic fit
Type 1 and type 2 diabetes: pathogenesis, prevention, glucose-lowering therapy, and
management trials.
Diabetes epidemiology and population science: incidence, risk factors, and outcomes across
cohorts.
Islet and beta-cell biology, insulin secretion and action, and metabolic mechanism in cells
and animal models.
Diabetic complications: nephropathy, retinopathy, neuropathy, and cardiovascular disease in
diabetes, with mechanism or outcome rigor.
Gestational diabetes, monogenic diabetes, and metabolic phenotyping studies.